| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 18.8MM | +8% |
| Operating Income | -148.9MM | - |
| Operating Expenses | 167.7MM | - |
| Net Income | -148.4MM | - |
| R&D | 32.2MM | -13% |
| G&A | 9.9MM | -38% |
| Marketing | 6.2MM | -12% |
| Amortization | 2.1MM | -12% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
SAN DIEGO, March 20, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage:
Listen, if you haven’t gotten the memo, penny stocks are incredibly dangerous. Yes, they’re cheap – in this case, extremely cheap. For the uninitiated, you might believe that shares can’t get any lower. Wrong! They can go down to zero. And before that happens, they can trade in fractions of a penny. At the same time, there are a few rare penny stocks that trade for less than a quarter that have analyst backing. It could just be one voice, an effort to break into a crowded arena. While I wouldn’t
Cue Health Inc. (NASDAQ:HLTH) Q4 2023 Earnings Call Transcript March 13, 2024 Cue Health Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.45. HLTH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for […]
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 28.89% and 6.81%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
SAN DIEGO, March 13, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023.
SAN DIEGO, February 28, 2024--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
SAN DIEGO, February 16, 2024--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced it entered into a cooperation agreement (the "Cooperation Agreement") with Tarsadia Investments ("Tarsadia"), and appointed Rishi Reddy to its board of directors (the "Board"), effective immediately. Mr. Reddy is a Managing Director at Tarsadia, where he leads the firm’s venture and growth equity strategy. He was previously an Observer on Cue’s Board of Directors from April 2018 to September
The company cut 94 workers at the beginning of last month and another 151 people on Jan. 25.
SAN DIEGO, January 31, 2024--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 13, 2024.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...